Stockscreener 앱 받기
1.025
0.49%
-0.005
시간 외 거래:
1.03
0.005
+0.49%
전일 마감가:
$1.03
열려 있는:
$1.03
하루 거래량:
17,911
Relative Volume:
0.13
시가총액:
$5.84M
수익:
-
순이익/손실:
$-3.12M
주가수익비율:
-0.2129
EPS:
-4.8149
순현금흐름:
$-2.69M
1주 성능:
+8.80%
1개월 성능:
+15.17%
6개월 성능:
-54.04%
1년 성능:
-36.34%
1일 변동 폭
$1.00
$1.0484
1주일 범위
$0.98
$1.14
52주 변동 폭
$0.6578
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
명칭
180 Life Sciences Corp
전화
650-507-0669
주소
3000 EL CAMINO REAL, PALO ALTO
ATNF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
1.025 | 5.37M | 0 | -3.12M | -2.69M | -4.8149 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-15 | 개시 | Maxim Group | Buy |
180 Life Sciences Corp 주식(ATNF)의 최신 뉴스
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Best Toy Stocks To Watch Now – May 25th - Defense World
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace
180 Life Sciences’ (ATNF) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World
180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com
ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com
MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal
180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus
180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India
180 Life Sciences nears patent for post-surgery cognitive aid - Investing.com
180 Life Sciences Corp. Announces Notice of Allowance for U.S. P - GuruFocus
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction | ATNF Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan
Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal
180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India
180 Life Sciences Settles Disputes with Elray Resources - TipRanks
180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia
180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World
Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World
Q4 Results This Week: BPCL, Varun Beverages, Vedanta, SBI, Trent Among 180+ Companies To Declare Earnings - NDTV Profit
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Dupuytren's Disease Market Valuation Expected To Reach $8.54 Billion By 2029 Growing At A Rate Of 9% As Rev... - WhaTech
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - Yahoo Finance
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter
ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences - Siemens press
180 Life Sciences Corp. SEC 10-K Report - TradingView
ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com
180 Life Sciences Corp. (ATNF) reports earnings - qz.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World
180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR
180 Life Sciences Corp (ATNF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):